3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
13
Head and Neck Neoplasms
12
Stomatitis
10
Neoplasms
8
Radiodermatitis
7
Lymphedema
6
Mucositis
5
Xerostomia
4
Radiation Injuries
4
Trismus
3
Peripheral Nervous System Diseases
2
Hematologic Neoplasms
2
Fibrosis
2
Dermatitis
2
Breast Cancer Lymphedema
2
Wounds and Injuries
1
Taste Disorders
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Diseases
1
Radiation Induced Xerostomia
1
Radiation Fibrosis Syndrome
1
Pain
1
Ovarian Neoplasms
1
Neuralgia
1
Mouth Neoplasms
1
Hand-Foot Syndrome
1
Graft vs Host Disease
1
Gastrointestinal Neoplasms
1
Eczema
1
Bone Marrow Neoplasms
1
Interventions
Celecoxib
2
Capecitabine
2
tegafur-gimeracil-oteracil
1
mecobalamin
1
liposomal doxorubicin
1
Urea
1
Tobacco Use Cessation Devices
1
Standard of Care
1
S 1 (combination)
1
Radiotherapy
1
Pyridoxine
1
Pharmacokinetics
1
Medicine, Chinese Traditional
1
Low-Level Light Therapy
1
Diclofenac
1
Brimonidine Tartrate
1
Blood Specimen Collection
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hand-Foot Syndrome
×
Low-Level Light Therapy
×
Clear all
NCT04979078
2023-06-18
DermLight
Jessa Hospital
Phase NA
Recruiting
40 enrolled